Assessment of treatment response by autoradiography with 14C-aminocyclopentane carboxylic acid, 67Ga-DTPA, and 18F-FDG in a herpes simplex virus thymidine kinase/ganciclovir brain tumor model

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1845-1854

  Miyagawa, Tadashi ^a,b   Oku, Takamitsu ^a,c   Sasajima, Toshio ^a,d   Dasai, Rovathi ^a   Beattie, Bradley ^a   Finn, Ronald ^a   Tjuvajev, Juri Gelovani ^a   Blasberg, Ronald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aminocyclopentane carboxylic acid; Autoradiography; DTPA; FDG; Herpes simplex virus 1 ganciclovir

Indexed keywords

CARBON 14; CYCLOLEUCINE; CYCLOLEUCINE C 14; DIETHYLENETRIAMINOPENTAACETIC ACID GA 67; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GANCICLOVIR; GLUCOSE; PENTETIC ACID; SODIUM CHLORIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GALLIUM;

AMINO ACID TRANSPORT; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE THERAPY; GLUCOSE UTILIZATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; MEDICAL ASSESSMENT; MICROVASCULATURE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; SURVIVAL RATE; TOXICITY; XENOGRAFT; ANIMAL; ENZYMOLOGY; FISCHER 344 RAT; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; RAT; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; AUTORADIOGRAPHY; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYCLOLEUCINE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; GANCICLOVIR; GENE THERAPY; HUMANS; MALE; PENTETIC ACID; RATS; RATS, INBRED F344; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0642284532     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ram Z, Walbridge S, Shawker T, et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Nearosurg. 1994;81:256-260.
2. Culver KW, Van Gilder J, Link CJ, et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther. 1994;5:343-379.
3. Klatzmann D, Valery CA, Bensimon G, et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma: Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther. 1998;9:2595-2604.
4. Shand N, Weber F, Manani L, et al. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir GL1328 European-Canadian Study Group. Hum Gene Ther. 1999,10:2325-2335
5. Fels C, Schafer C, Huppe B, et al. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. J Neurooncol. 2000;48:207-216.
6. Wildner O. In situ use of suicide genes for therapy of brain tumours. Ann Med. 1999;31:421-429.
7. Blasberg R, Tjuvajev J. In vivo monitoring of gene therapy by radiotracer imaging. In. Semmler W, Schwaiger M, eds Ernst Shering Research Foundation Workshop 22: Impact of Molecular Biology and New Technical Developments on Diagnostic Imaging. Berlin-Heidelberg, Germany Springer Verlag; 1997:161-189
8. Tjuvajev JG, Finn R, Watanabe K, et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 1996;56:4087-4095
9. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998;58:4333-4341.
10. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995;55:6126-6132.
11. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 1999,96:2333-2338.
12. Kanai Y, Segawa H, Miyamoto K, et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273:23629-23632.
13. Nakamura E, Sato M, Yang H, et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer J Biol Chem. 1999;274:3009-3016.
14. Miyagawa T, Oku T, Uehara H, et al. "Facilitated" amino acid transport is upregulated in brain tumors J Cereb Blood Flow Metab. 1998;18:500-509.
15. Wildner O, Blaese RM, Morris JC. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res 1999;59:410-413.
16. Morin KW, Knaus EE, Wiebe LI, et al. Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase. Nucl Med Commun 2000;21:129-137.
17. Haberkorn U, Bellemann ME, Gerlach L, et al Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther. 1998;5:880-887.
18. Haberkorn U, Altmann A, Kamencic H, et al Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. Eur J Nucl Med 2001;28:1690-1696.
19. Ross BD, Kim B, Davidson BL. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Clin Canrer Res. 1995,1:651-657.
20. Haberkorn U, Altmann A, Morr I, et al. Multitracer studies during gene therapy of hepatoma cells with HSV thymidine kinase and ganciclovir. J Nucl Med 1997;38:1048-1054.
21. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
22. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
23. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res. 1982;257:237-274.
24. Uehara H, Miyagawa T, Tjuvajev J, et al. Imaging experimental brain tumors with 1-aminocyclotentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethyleneaminenentaacetic acid in morphologically defined tumor regions. J Cereb Blood Flow Metab. 1997;17:1239-1253.
25. Blasberg RG, Kobayashi T, Patlak CS, et al Regional blood flow, capillary permeability, and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications. Cancer Treat Rep. 1981;65:3-12.
26. Blasberg RG, Kobayashi T, Horowitz M, et al. Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors Ann Neurol 1983;14:202-215.
27. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978;235:H299-H307.
28. Tjuvajev JG, Chen SH, Joshi A, et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 1999;59:5186-5193
29. Marton A, Gustine T, Le-Roux A, et al Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow up by magnetic resonance imaging. Gene Ther. 1996,3:315-322.
30. Ram Z, Culver K, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med. 1997; 3:1354-1361.
31. Namba H, Iwadate Y, Tagawa M, et al. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging. Hum Gene Ther. 1996;7:1847-1852.
32. 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:176-182
33. 3H]thymidine, and gallium-67 J Nucl Med. 1991,32:2118-2123.
34. 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo. Br J Cancer. 1993;67:701-705
35. Haberkorn U, Remhardt M, Strauss LG, et al. Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy. J Nucl Med. 1992,33:1981-1987
36. Kageyama T, Nakamura M, Matsuo A, et al. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 2000;879:115-121.
37. Killian DM, Chikhale PJ Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci Lett. 2001,306:1-4
38. Haberkorn U, Ziegler SI, Oberdorfer F, et al FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models Nucl Med Biol. 1994;21:827-834.
39. Schaider H, Haberkorn U, Berger MR, et al Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D- glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med. 1996;23:55-60.
40. 124I]iododeoxyuridine. Cancer Res. 2000;60:624-635